Tag: Ulcerative Colitis
Persistent Fluorinated Chemicals Tied to Higher Risk for Inflammatory Bowel Disease
Odds for Crohn disease and ulcerative colitis increased with higher serum perfluoroalkyl and polyfluoroalkyl substance levels up to 10 years before diagnosis
Histologic Inflammation With IBD Tied to Serious Infections
Authors say achieving histologic remission for both Crohn disease and ulcerative colitis may reduce the risk for serious infections
Inflammatory Bowel Disease Increases Risk for Later Arrhythmias
Findings seen for inflammatory bowel disease overall, as well as individual diseases
FDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults
Significant benefits at 12 weeks include clinical remission, endoscopic improvement, mucosal healing
Lower Fiber Intake Tied to Higher Risk for Later Inflammatory Bowel Disease
Findings seen for Crohn disease, but not ulcerative colitis
Mirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
Mirikizumab more effective for inducing and maintaining clinical remission in patients with ulcerative colitis
Small Increase in Lymphoma Risk Seen With Crohn Disease, Ulcerative Colitis
Hazard ratios highest for patients exposed to immunomodulators and biologics or second-line biologics
Vedolizumab Aids Remission in Chronic Pouchitis After Ileal Pouch-Anal Anastomosis
Findings seen in patients with chronic pouchitis after ileal pouch-anal anastomosis for ulcerative colitis
Clinical Guideline Developed for Use of Biomarkers in Ulcerative Colitis
Guideline suggests use of biomarker- and symptom-based monitoring strategy over symptom-based strategy for patients in symptomatic remission
AI Model Can Help Identify Ulcerative Colitis Remission, Activity
Model can also predict flare-ups, clinical outcomes
